Agilent Technologies Inc (A)vsBiodesix Inc (BDSX)
A
Agilent Technologies Inc
$126.49
-2.12%
HEALTHCARE · Cap: $36.67B
BDSX
Biodesix Inc
$17.35
-6.30%
HEALTHCARE · Cap: $161.55M
Smart Verdict
WallStSmart Research — data-driven comparison
Agilent Technologies Inc generates 7426% more annual revenue ($7.23B vs $96.10M). A leads profitability with a 19.6% profit margin vs -33.3%. A earns a higher WallStSmart Score of 71/100 (B).
A
Strong Buy71
out of 100
Grade: B
BDSX
Avoid31
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-73.0%
Fair Value
$74.53
Current Price
$126.49
$51.96 premium
Margin of Safety
-19.0%
Fair Value
$8.70
Current Price
$17.35
$8.65 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 60.0% YoY
Strong operational efficiency at 23.7%
Revenue surging 42.3% year-over-year
Areas to Watch
Moderate valuation
Grey zone — moderate risk
Weak financial health signals
Trading at 19.3x book value
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -349.9% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : A
The strongest argument for A centers on EPS Growth, Operating Margin. Profitability is solid with margins at 19.6% and operating margin at 23.7%. PEG of 1.28 suggests the stock is reasonably priced for its growth.
Bull Case : BDSX
The strongest argument for BDSX centers on Revenue Growth. Revenue growth of 42.3% demonstrates continued momentum.
Bear Case : A
The primary concerns for A are P/E Ratio, Altman Z-Score, Piotroski F-Score.
Bear Case : BDSX
The primary concerns for BDSX are Price/Book, EPS Growth, Market Cap. Debt-to-equity of 7.84 is elevated, increasing financial risk.
Key Dynamics to Monitor
A profiles as a mature stock while BDSX is a hypergrowth play — different risk/reward profiles.
A carries more volatility with a beta of 1.26 — expect wider price swings.
BDSX is growing revenue faster at 42.3% — sustainability is the question.
A generates stronger free cash flow (184M), providing more financial flexibility.
Bottom Line
A scores higher overall (71/100 vs 31/100), backed by strong 19.6% margins. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Agilent Technologies Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California.
Biodesix Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company is headquartered in Boulder, Colorado.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?